Bci pharma sa
WebMar 12, 2024 · BCI Pharma is a biopharmaceutical company that designs and synthesizes kinase inhibitor libraries. Grabels, Languedoc-Roussillon, France 1-10 Venture - Series … WebBCI Pharma SA TheClubDeal Sector: Life Sciences Fund: Club I Team: Dominique Surleraux Description BCI Pharma is a company existing for 5 years in Montpellier, …
Bci pharma sa
Did you know?
WebBCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery. We have developed a Platform/Technology to deliver Novel, Potent and Selective Kinase Inhibitors. Our goal is to identify Potent and selective preclinical candidates to improve cancer, inflammation, neuroinflammation and pain treatments. ... WebA LEED-NC Gold headquarters complex serves the recent merger of two Japanese pharmaceutical companies and the new company’s commitment to reduce its carbon footprint. The complex establishes a confident, …
WebApr 9, 2014 · Website www.bci-pharma.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Biotechnology Other … WebBCI Pharma has raised a total of €3.9M in funding over 2 rounds. Their latest funding was raised on Mar 12, 2024 from a Venture - Series Unknown round. BCI Pharma is funded by TheClubDeal. Funding Rounds Number of Funding Rounds 2 Total Funding Amount €3.9M BCI Pharma has raised a total of €3.9M in funding over 2 rounds.
WebBCI Pharma is an innovative biopharmaceutical company focused on small molecule drug discovery.We design and synthesize innovative kinase inhibitors libraries and combine with our HTS technology (Target and cell based assays). Thanks to our relevant platforms, we identify Novel, Potent and Selective Kinase Inhibitor Hits which are further optimized to … WebAug 24, 2024 · Contract packaging company PCI Pharma Services (Philadelphia, PA, US) has begun its official bidding process for a sale valued at $2.5B. The buyer can expect to …
WebSep 5, 2024 · Developer BCI Pharma; University of Bergen Class Antineoplastics; Small molecules Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Macrophage colony stimulating factor receptor antagonists Orphan Drug Status No New Molecular Entity Yes Available For Licensing Yes - Acute myeloid leukaemia Highest Development Phases
WebJul 6, 2024 · BCI Pharma is a biotech company that focuses on the discovery and development of novel, selective and very potent kinase inhibitors for high unmet medical needs, such as peripheral neuropathic pain, psoriasis, … ray platt towingWebBCI PHARMA - We take care of your health 414 (na) tagasubaybay sa LinkedIn. BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery. We design innovative chemical libraries and our HTS platform can support your owned library synthesis. Founded by : - Dr. simply bootsWebBASIC CHEMICAL INDUSTRIES (BCI)THE INDUSTRY LEADER. Since its inception in 1973, Basic Chemical Industries (BCI) has grown impressively to become one of the leading chemical companies in the Kingdom of Saudi Arabia. Located in the Eastern Province of the Kingdom, the company’s headquarters, its manufacturing plant and main … rayplay accessoWebBCI Pharma is a biopharmaceutical company focused on small molecule drug discovery. It designs a platform to identify potent and selective kinase inhibitors. The company provides target-based assay screening technology and chemotype with phys-chem properties delivering drugs for treating chronic pain, CNS, inflammation, cancer, and metabolic ... ray play app da installareWebThe entry of this data is necessary for the processing of the internet user’s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 of 6 January 1978 relating to data processing, files and modified freedoms and to Regulation (EU) 2016/679 of the European Parliament and of the Council of April ... ray play arteWebMar 6, 2024 · BCI Pharma signs a strategic partnership with Mithra BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the rights relating to BCI development program on innovative inhibitors of CSF1R kinase indicated for the treatment of female cancers and endometriosis. Press release 11/29/2024 by BCI PHARMA ray plattWebFeb 28, 2024 · BCI Pharma's latest funding round was a Unattributed VC for on February 28, 2024. Date. Round. Amount. Investors. Valuation. Valuations are submitted by … rayplay 3 toscana